Nasdaq rose 0.03% to 21,886.06 for its third consecutive record-high close. The S&P 500 gained 0.30% to end the session at 6,532.04, closing with a record high for the second straight day.

The Institute for Clinical and Economic Review (ICER) on Tuesday released a Draft Evidence Report assessing the comparative ...

In response to what it says is "deceptive" pharmaceutical ads, the FDA sent out "100 cease-and-desist letters" to brands - a move that could have massive impact on pharma's $7 billion U.S. national TV ...

The Danish pharmaceutical giant, which is looking to revive growth, used to be Europe's most valuable company listed on ...

In response to what it says is "deceptive" pharmaceutical ads, the FDA sent out "100 cease-and-desist letters" to brands - a move that could have massive impact on pharma's $7 billion U.S. national TV ...

Novo Nordisk will lay off 9,000 employees worldwide as part of a restructuring plan, redirecting savings to diabetes and obesity drug growth.

The restructuring, which would eliminate 11% of the company's workforce, aimed to reduce organizational complexity and speed ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Novo Nordisk is cutting 9,000 jobs to save $1.25 billion annually and reignite growth. Facing competition from Eli Lilly, the ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Novo Nordisk announces a major restructuring, including 9,000 job cuts, to save $1.25 billion annually and regain market ...

Lilly, which sells the Alzheimer’s drug Kisunla, has recruited Moore to its global “Brain Health Matters” campaign. Drawing ...